Effects of the adenosine A2A antagonist istradefylline on cognitive performance in rats with a 6-OHDA lesion in prefrontal cortex (Q45341017)

13 December 2017

Effects of the adenosine A2A antagonist istradefylline on cognitive performance in rats with a 6-OHDA lesion in prefrontal cortex (English)

1 reference

13 December 2017

Takako Kadowaki Horita

1

1 reference

13 December 2017

Minoru Kobayashi

2

1 reference

13 December 2017

Akihisa Mori

3

1 reference

13 December 2017

Peter Jenner

4

1 reference

13 December 2017

Tomoyuki Kanda

5

1 reference

13 December 2017

10 June 2013

1 reference

13 December 2017

8

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

13 December 2017

230

1 reference

13 December 2017

3

1 reference

13 December 2017

345-352

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-013-3158-x

13 December 2017

0 references

cites work

A systematic review of prevalence studies of dementia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Differential effects of caffeine on dopamine and acetylcholine transmission in brain areas of drug-naive and caffeine-pretreated rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Distribution of adenosine A(2A) receptor antagonist KW-6002 and its effect on gene expression in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Cognitive correlates of cortical cholinergic denervation in Parkinson's disease and parkinsonian dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Cognitive Deficit Caused by Regional Depletion of Dopamine in Prefrontal Cortex of Rhesus Monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Desipramine attenuates working memory impairments induced by partial loss of catecholamines in the rat medial prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Enhanced role of adenosine A(2A) receptors in the modulation of LTP in the rat hippocampus upon ageing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Attention and executive function deficits in chronic low-dose MPTP-treated non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Tissue distribution of adenosine receptor mRNAs in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Cognitive deficits in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

A new one-trial test for neurobiological studies of memory in rats. III. Spatial vs. non-spatial working memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Mesocortical dopamine modulation of executive functions: beyond working memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

The effect of the selective reversible acetylcholinesterase inhibitor E2020 on extracellular acetylcholine and biogenic amine levels in rat cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Working memory deficits in transgenic rats overexpressing human adenosine A2A receptors in the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Effects of rat medial prefrontal cortex temporal inactivation on a delayed alternation task

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Istradefylline, a novel adenosine A2A receptor antagonist, for the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Adenosine, adenosine A 2A antagonists, and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Combined use of the adenosine A(2A) antagonist KW-6002 with L-DOPA or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Comparative studies of huperzine A, donepezil, and rivastigmine on brain acetylcholine, dopamine, norepinephrine, and 5-hydroxytryptamine levels in freely-moving rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Cellular and behavioural effects of the adenosine A2a receptor antagonist KW-6002 in a rat model of l-DOPA-induced dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Characteristic of cognitive decline in Parkinson's disease: a 1-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Pharmacological characterization of a novel, potent adenosine A1 and A2A receptor dual antagonist, 5-[5-amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one (ASP5854), in models of Parkinson's disease and cognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Evaluation of distribution of adenosine A2A receptors in normal human brain measured with [11C]TMSX PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Clinical efficacy of istradefylline (KW-6002) in Parkinson's disease: a randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Perspectives on object-recognition memory following hippocampal damage: lessons from studies in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Systemic administration of adenosine A(2A) receptor antagonist reverses increased GABA release in the globus pallidus of unilateral 6-hydroxydopamine-lesioned rats: a microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

The effect of striatal dopamine depletion and the adenosine A2A antagonist KW-6002 on reversal learning in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Cognitive impairment and dementia in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Activation of adenosine receptors in the posterior cingulate cortex impairs memory retrieval in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Modulation of short-term social memory in rats by adenosine A1 and A(2A) receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Antagonistic interaction between adenosine A2A and dopamine D2 receptors modulates the social recognition memory in reserpine-treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Caffeine reverses age-related deficits in olfactory discrimination and social recognition memory in rats. Involvement of adenosine A1 and A2A receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Blockade of adenosine A2A receptors reverses short-term social memory impairments in spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Worsening of motor function and mood in a patient with Parkinson's disease after pharmacologic challenge with oral rivastigmine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Spatial delayed alternation of rats in a T-maze: effects of neurotoxic lesions of the medial prefrontal cortex and of T-maze rotations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Attentional set-shifting deficit in Parkinson's disease is associated with prefrontal dysfunction: an FDG-PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

What contributes to quality of life in patients with Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

21 January 2018

12 December 2020

Effects of cholinesterase inhibitors in Parkinson's disease dementia: a review of clinical data

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Object recognition impairment in Fmr1 knockout mice is reversed by amphetamine: involvement of dopamine in the medial prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Improved spatial recognition memory in mice lacking adenosine A2A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Normal and abnormal functions of adenosine receptors in the central nervous system revealed by genetic knockout studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Preferential enhancement of working memory in mice lacking adenosine A(2A) receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Modulation of GABAergic transmission in the striatopallidal system by adenosine A2A receptors: a potential mechanism for the antiparkinsonian effects of A2A antagonists

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

21 January 2018

12 December 2020

Purine modulation of dizocilpine effects on spontaneous alternation

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3158-X

Increase of extracellular dopamine in primate prefrontal cortex during a working memory task

21 January 2018

1 reference

12 December 2020

Cholinesterase inhibitor effects on neurotransmitters in rat cortex in vivo.

1 reference

12 December 2020

Adenosine and memory storage: effect of A(1) and A(2) receptor antagonists.

1 reference

12 December 2020

1 reference

12 December 2020

Adenosine A(2A) receptor antagonists KF17837 and KW-6002 potentiate rotation induced by dopaminergic drugs in hemi-Parkinsonian rats

1 reference

12 December 2020

10.1007/S00213-013-3158-X

Identifiers

DOI

1 reference

Dimensions Publication ID

13 December 2017

0 references

1 reference